Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
Integra LifeSciences (Nasdaq: IART) announced that CEO Mojdeh Poul and CFO Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m. ET.
Rhea-AI Summary
Integra LifeSciences (Nasdaq: IART) announced that CEO Mojdeh Poul and CFO Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m. ET. A live webcast will be available on the company investor relations website under Events & Presentations.
Positive
- None.
Negative
- None.
Details
News Market Reaction – IART
In the Dec 2 session, IART gained 0.77%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference date
- December 3, 2025
- Citi 2025 Global Healthcare Conference presentation
- Presentation time
- 10:30 a.m. ET
- Scheduled time for Integra LifeSciences management remarks
Historical Context
-
Management scheduled to present at Citi 2025 Global Healthcare Conference.
-
Medicare rules expanded uniform reimbursement for multiple Integra skin substitutes.
-
FDA 510(k) clearance extended CUSA Clarity use to cardiac surgeries.
-
Q3 2025 showed revenue and EPS growth but stock fell sharply.
-
Announcement of Q3 2025 results release and conference call timing.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.